NO975527L - Anvendelse av alendronat til forhindring av osteoporose - Google Patents

Anvendelse av alendronat til forhindring av osteoporose

Info

Publication number
NO975527L
NO975527L NO975527A NO975527A NO975527L NO 975527 L NO975527 L NO 975527L NO 975527 A NO975527 A NO 975527A NO 975527 A NO975527 A NO 975527A NO 975527 L NO975527 L NO 975527L
Authority
NO
Norway
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
NO975527A
Other languages
English (en)
Other versions
NO975527D0 (no
Inventor
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO975527D0 publication Critical patent/NO975527D0/no
Publication of NO975527L publication Critical patent/NO975527L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO975527A 1995-06-02 1997-12-01 Anvendelse av alendronat til forhindring av osteoporose NO975527L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
NO975527D0 NO975527D0 (no) 1997-12-01
NO975527L true NO975527L (no) 1997-12-01

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975527A NO975527L (no) 1995-06-02 1997-12-01 Anvendelse av alendronat til forhindring av osteoporose

Country Status (21)

Country Link
EP (1) EP0828496A1 (no)
JP (1) JPH10506648A (no)
KR (1) KR19990022436A (no)
CN (1) CN1192685A (no)
AU (1) AU709196B2 (no)
BG (1) BG63103B1 (no)
BR (1) BR9609020A (no)
CA (1) CA2222318A1 (no)
CZ (1) CZ381197A3 (no)
EA (1) EA000677B1 (no)
EE (1) EE03306B1 (no)
HU (1) HUP9900659A3 (no)
IL (1) IL118422A0 (no)
IS (1) IS4617A (no)
NO (1) NO975527L (no)
NZ (1) NZ308935A (no)
PL (1) PL323669A1 (no)
SK (1) SK159597A3 (no)
TR (1) TR199701482T1 (no)
WO (1) WO1996038156A1 (no)
ZA (1) ZA964465B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
WO2002089816A1 (en) * 2001-05-02 2002-11-14 Novartis Ag Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
EA000677B1 (ru) 2000-02-28
WO1996038156A1 (en) 1996-12-05
TR199701482T1 (xx) 1998-03-21
BR9609020A (pt) 1999-07-06
AU709196B2 (en) 1999-08-26
EA199700449A1 (ru) 1998-06-25
CZ381197A3 (cs) 1998-06-17
NZ308935A (en) 2000-07-28
AU5882496A (en) 1996-12-18
HUP9900659A3 (en) 2002-12-28
EE03306B1 (et) 2000-12-15
BG102060A (en) 1998-07-31
NO975527D0 (no) 1997-12-01
KR19990022436A (ko) 1999-03-25
JPH10506648A (ja) 1998-06-30
ZA964465B (en) 1996-12-11
IS4617A (is) 1997-11-19
PL323669A1 (en) 1998-04-14
BG63103B1 (bg) 2001-04-30
CN1192685A (zh) 1998-09-09
HUP9900659A2 (hu) 2001-04-28
EP0828496A1 (en) 1998-03-18
CA2222318A1 (en) 1996-12-05
IL118422A0 (en) 1996-09-12
SK159597A3 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
DE69604788T2 (de) Hydrosilylierung von ungesättigten verbindungen
NO950760D0 (no) Fremgangsmåte for fremstilling av alkylhalosilaner
ID19439A (id) Peningkatan pada senyawa organik atau yang terkait
NO952986L (no) Anordning til innbyrdes befestigelse av to innretninger
NO982043D0 (no) Sammensetning av polyisocyanat
IT1276799B1 (it) Formulazioni di f-silicone
NO975527L (no) Anvendelse av alendronat til forhindring av osteoporose
ID17424A (id) Penghambat matriks metaloproteasa oleh senyawa-senyawa fenetil tersubstitusi
NO980862D0 (no) Zwitterinoformer av trovafloxacin
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
NO964685D0 (no) Isomering av equilin
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
KR970000111U (ko) 도계 설비 시스템의 3차 이양기
AT204U3 (de) Fussabstreifer
KR970010637U (ko) 물분배기의 개폐장치
KR970036510U (ko) Abs시스템의 모듈레이터 고정구조
SE9503245D0 (sv) Framställning av optokomponentplatta
NO955296D0 (no) Fremgangsmåte for fremstilling av betongkonstruksjon
FI950265A (fi) Elementtirakenteinen seinä
NO973476D0 (no) Fremgangsmåte for fremstilling av alkylhalosilaner
NO945058D0 (no) Anvendelse av fosfonater for behandling av osteoporose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application